Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple ascending-dose study of JNJ-54175446 in healthy male volunteers
NL-OMON42646Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of JNJ-54175446 in major depressive disorder (MDD) and affective disorder (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Safety, Tolerability and 1 more. Started Aug 2015; status: active, not recruiting.
02
Drugs
JNJ-54175446
03
Conditions
major depressive disorder (MDD)affective disorder
Beyond the preview
Go deeper on NL-OMON42646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42646.